NCT01635244

Brief Summary

The purpose of this study is to:

  1. 1.Assess for hemodynamic differences at rest and with exercise between three clinically available tissue aortic valves.
  2. 2.Assess for differences in left ventricular (LV) reverse remodeling (recovery of LV hypertrophy, and changes in LV systolic and diastolic function) after aortic valve replacement for severe aortic stenosis (AS) between three clinically available aortic valve bioprosthesis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2012

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 9, 2012

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

February 3, 2017

Completed
Last Updated

February 3, 2017

Status Verified

December 1, 2016

Enrollment Period

3.4 years

First QC Date

July 1, 2012

Results QC Date

December 10, 2016

Last Update Submit

December 10, 2016

Conditions

Keywords

Aortic valve prosthesisAortic valve hemodynamicsProsthesis-patient mismatchLeft ventricular diastolic functionLeft ventricular remodeling

Outcome Measures

Primary Outcomes (1)

  • Aortic Valve Mean Gradient (mm Hg) at Peak Exercise

    This is a measure of the resistance to flow across the aortic bioprosthesis.

    6 months after aortic valve replacement

Study Arms (3)

Freestyle

ACTIVE COMPARATOR

Aortic valve replacement will be performed with a Freestyle stentless aortic bioprosthesis (Medtronic Cardiovascular; Minneapolis, MN).

Device: Aortic valve replacement

Magna Ease

ACTIVE COMPARATOR

Aortic valve replacement will be performed with a Magna Ease aortic bioprosthesis (Edwards Lifesciences; Irvine, CA).

Device: Aortic valve replacement

Trifecta

ACTIVE COMPARATOR

Aortic valve replacement will be performed with a Trifecta aortic bioprosthesis (St. Jude Medical; St. Paul, MN).

Device: Aortic valve replacement

Interventions

Clinically indicated aortic valve replacement will be performed using one of three approved tissue valves (Freestyle, Magna Ease, or Trifecta).

FreestyleMagna EaseTrifecta

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Severe aortic stenosis (AS) based on overall clinical impression, with or without aortic valve mean gradient ≥ 40 mm Hg, EOA \< 1.0 cm2, or EOA index \< 0.6 cm2/m2.
  • Scheduled for clinically indicated elective aortic valve replacement for a primary diagnosis of severe AS.
  • Less than moderate aortic regurgitation on preoperative testing.
  • Isolated aortic valve replacement; or aortic valve replacement with concomitant coronary artery bypass grafting, ascending aorta repair, or mitral and/or tricuspid annuloplasty for functional mitral regurgitation / tricuspid regurgitation.
  • Left ventricular ejection fraction ≥ 40% on preoperative testing.
  • Physically able and willing to pedal a recumbent bicycle.
  • Patient and surgeon agree that the patient will undergo valve replacement with a bioprosthesis.
  • Patient and surgeon agree that the use of one specific bioprosthesis manufacturer / model is not indicated based on clinical criteria.
  • Willing to undergo randomization to have implanted one of three bioprosthesis at the time of aortic valve replacement.
  • Willing and able to undergo preoperative echocardiography/Doppler for purposes of the research study.
  • Willing and able to undergo post-operative exercise stress echocardiography/Doppler 5 to 7 months after valve replacement for purposes of the research protocol.

You may not qualify if:

  • Age \< 18 years.
  • AS felt by overall clinical impression to be less than severe.
  • Aortic valve replacement is urgent or emergent.
  • Moderate of more aortic regurgitation on preoperative testing.
  • Concomitant mitral or tricuspid valve replacement.
  • Left ventricular ejection fraction \< 40% on preoperative testing.
  • Physically unable or unwilling to pedal a recumbent bicycle.
  • Planned aortic valve replacement with a mechanical prosthesis.
  • Operating surgeon believes that any one of the three protocol bioprosthetic devices is contraindicated based on clinical criteria.
  • Not willing to undergo randomization to have implanted one of three bioprosthesis.
  • Unwilling or unable to undergo preoperative echocardiography/Doppler for purposes of the research protocol.
  • Unwilling or unable to undergo post-operative exercise stress echocardiography/Doppler 5 to 7 months after valve replacement for purposes of the research protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan Health Systems

Ann Arbor, Michigan, 48109, United States

Location

Related Publications (1)

  • Bach DS, Patel HJ, Kolias TJ, Deeb GM. Randomized comparison of exercise haemodynamics of Freestyle, Magna Ease and Trifecta bioprostheses after aortic valve replacement for severe aortic stenosis. Eur J Cardiothorac Surg. 2016 Aug;50(2):361-7. doi: 10.1093/ejcts/ezv493. Epub 2016 Jan 27.

MeSH Terms

Conditions

Aortic Valve StenosisVentricular Remodeling

Interventions

Transcatheter Aortic Valve Replacement

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow ObstructionPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Heart Valve Prosthesis ImplantationCardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeProsthesis ImplantationThoracic Surgical Procedures

Results Point of Contact

Title
David Bach, MD
Organization
University of Michigan

Study Officials

  • David Bach, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

July 1, 2012

First Posted

July 9, 2012

Study Start

July 1, 2012

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

February 3, 2017

Results First Posted

February 3, 2017

Record last verified: 2016-12

Locations